Chantal Allamargot

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Skeletal Muscle

Diabetic Nephropathy

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jillian Williquett, Chantal Allamargot, Hua Sun
AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy. Kidney360 5 (4) (2024)
Jillian Williquett, Chantal Allamargot, Hua Sun
AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy. Kidney360 (2024)
Jillian Williquett, Chantal Allamargot, Hua Sun
AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy. Kidney360 5 (4) (2024)
Jillian Williquett, Chantal Allamargot, Hua Sun
AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy. Kidney360 5 (4) (2024)
Jillian Williquett, Chantal Allamargot, Hua Sun
AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy. Kidney360 5 (4) (2024)
Jillian Williquett, Chantal Allamargot, Hua Sun
AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy. Kidney360 5 (4) (2024)
Jillian Williquett, Chantal Allamargot, Hua Sun
AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy. Kidney360 5 (4) (2024)
Jillian Williquett, Chantal Allamargot, Hua Sun
AMPK-SP1-Guided Dynein Expression Represents a New Energy-Responsive Mechanism and Therapeutic Target for Diabetic Nephropathy. Kidney360 5 (4) (2024)